APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetically Modified Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Genetically Modified Drug Industry Growth and Trends Forecast to 2032

22 December 2025119 pages

Choose your research edition.

Industry ResearchGenetically Modified Drug Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetically Modified Drug Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Genetically Modified Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetically Modified Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetically Modified Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Genetically Modified Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Genetically Modified Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Genetically Modified Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetically Modified Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genetically Modified Drug include Takeda, Sanofi, Johnson & Johnson, Novartis, Merck & Co., Roche, Eli Lilly, Pfizer and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Genetically Modified Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Genetically Modified Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genetically Modified Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genetically Modified Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Genetically Modified Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Genetically Modified Drug Market by Company

Takeda

Sanofi

Johnson & Johnson

Novartis

Merck & Co.

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Baxter

Amgen

Pharming Group NV

LFB Biotechnologies SA

F. Hoffmann-La Roche

Abbott Laboratories

Genetically Modified Drug Segment by Type

Transgenic Animal

Transgenic Plant

Genetically Modified Drug Segment by Application

Hospital

Clinic

Genetically Modified Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genetically Modified Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Genetically Modified Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Transgenic Animal Table 2. Major Company of Transgenic Plant Table 3. Global Genetically Modified Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 5. Global Genetically Modified Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Genetically Modified Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Genetically Modified Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Genetically Modified Drug Price by Type (2021-2026) & (US$/unit) Table 9. Global Genetically Modified Drug Sales by Type (2027-2032) & (k units) Table 10. Global Genetically Modified Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Genetically Modified Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Genetically Modified Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Genetically Modified Drug Price by Type (2027-2032) & (US$/unit) Table 14. North America Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 15. North America Genetically Modified Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 17. Europe Genetically Modified Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Genetically Modified Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 21. Latin America Genetically Modified Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Genetically Modified Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Genetically Modified Drug Industry Trends Table 25. Genetically Modified Drug Industry Drivers Table 26. Genetically Modified Drug Industry Opportunities and Challenges Table 27. Genetically Modified Drug Industry Restraints Table 28. Global Genetically Modified Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Genetically Modified Drug Revenue Market Share by Company (2021-2026) Table 30. Global Genetically Modified Drug Sales by Company (2021-2026) & (k units) Table 31. Global Genetically Modified Drug Sales Share by Company (2021-2026) Table 32. Global Genetically Modified Drug Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Genetically Modified Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Genetically Modified Drug Major Company Production Sites and Headquarters Table 35. Global Genetically Modified Drug Company, Product Type & Application Table 36. Global Genetically Modified Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Genetically Modified Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Genetically Modified Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Genetically Modified Drug Sales by Region (2021-2026) & (k units) Table 41. Global Genetically Modified Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Genetically Modified Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Genetically Modified Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Genetically Modified Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Genetically Modified Drug Sales by Region (2027-2032) & (k units) Table 46. Global Genetically Modified Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Genetically Modified Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Genetically Modified Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Genetically Modified Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Genetically Modified Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 52. Global Genetically Modified Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Genetically Modified Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Genetically Modified Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Genetically Modified Drug Price by Application (2021-2026) & (US$/unit) Table 56. Global Genetically Modified Drug Sales by Application (2027-2032) & (k units) Table 57. Global Genetically Modified Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Genetically Modified Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Genetically Modified Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Genetically Modified Drug Price by Application (2027-2032) & (US$/unit) Table 61. North America Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 62. North America Genetically Modified Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 64. Europe Genetically Modified Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Genetically Modified Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 68. Latin America Genetically Modified Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Genetically Modified Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Genetically Modified Drug Product Portfolio Table 75. Takeda Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sanofi Genetically Modified Drug Product Portfolio Table 80. Sanofi Recent Development Table 81. Johnson & Johnson Company Information Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Johnson & Johnson Genetically Modified Drug Product Portfolio Table 85. Johnson & Johnson Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Novartis Genetically Modified Drug Product Portfolio Table 90. Novartis Recent Development Table 91. Merck & Co. Company Information Table 92. Merck & Co. Business Overview Table 93. Merck & Co. Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Merck & Co. Genetically Modified Drug Product Portfolio Table 95. Merck & Co. Recent Development Table 96. Roche Company Information Table 97. Roche Business Overview Table 98. Roche Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Roche Genetically Modified Drug Product Portfolio Table 100. Roche Recent Development Table 101. Eli Lilly Company Information Table 102. Eli Lilly Business Overview Table 103. Eli Lilly Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Eli Lilly Genetically Modified Drug Product Portfolio Table 105. Eli Lilly Recent Development Table 106. Pfizer Company Information Table 107. Pfizer Business Overview Table 108. Pfizer Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Pfizer Genetically Modified Drug Product Portfolio Table 110. Pfizer Recent Development Table 111. GlaxoSmithKline Company Information Table 112. GlaxoSmithKline Business Overview Table 113. GlaxoSmithKline Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. GlaxoSmithKline Genetically Modified Drug Product Portfolio Table 115. GlaxoSmithKline Recent Development Table 116. Baxter Company Information Table 117. Baxter Business Overview Table 118. Baxter Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Baxter Genetically Modified Drug Product Portfolio Table 120. Baxter Recent Development Table 121. Amgen Company Information Table 122. Amgen Business Overview Table 123. Amgen Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Amgen Genetically Modified Drug Product Portfolio Table 125. Amgen Recent Development Table 126. Pharming Group NV Company Information Table 127. Pharming Group NV Business Overview Table 128. Pharming Group NV Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Pharming Group NV Genetically Modified Drug Product Portfolio Table 130. Pharming Group NV Recent Development Table 131. LFB Biotechnologies SA Company Information Table 132. LFB Biotechnologies SA Business Overview Table 133. LFB Biotechnologies SA Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. LFB Biotechnologies SA Genetically Modified Drug Product Portfolio Table 135. LFB Biotechnologies SA Recent Development Table 136. F. Hoffmann-La Roche Company Information Table 137. F. Hoffmann-La Roche Business Overview Table 138. F. Hoffmann-La Roche Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio Table 140. F. Hoffmann-La Roche Recent Development Table 141. Abbott Laboratories Company Information Table 142. Abbott Laboratories Business Overview Table 143. Abbott Laboratories Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Abbott Laboratories Genetically Modified Drug Product Portfolio Table 145. Abbott Laboratories Recent Development Table 146. North America Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. North America Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 148. North America Genetically Modified Drug Sales Market Share by Country (2021-2026) Table 149. North America Genetically Modified Drug Sales Forecast by Country (2027-2032) & (k units) Table 150. North America Genetically Modified Drug Sales Market Share Forecast by Country (2027-2032) Table 151. North America Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Genetically Modified Drug Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Genetically Modified Drug Market Share by Country (2021-2026) Table 154. North America Genetically Modified Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Genetically Modified Drug Market Share Forecast by Country (2027-2032) Table 156. Europe Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Europe Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 158. Europe Genetically Modified Drug Sales Market Share by Country (2021-2026) Table 159. Europe Genetically Modified Drug Sales Forecast by Country (2027-2032) & (k units) Table 160. Europe Genetically Modified Drug Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Genetically Modified Drug Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Genetically Modified Drug Market Share by Country (2021-2026) Table 164. Europe Genetically Modified Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Genetically Modified Drug Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 168. Asia-Pacific Genetically Modified Drug Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Genetically Modified Drug Sales Forecast by Country (2027-2032) & (k units) Table 170. Asia-Pacific Genetically Modified Drug Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Genetically Modified Drug Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Genetically Modified Drug Market Share by Country (2021-2026) Table 174. Asia-Pacific Genetically Modified Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Genetically Modified Drug Market Share Forecast by Country (2027-2032) Table 176. Latin America Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Latin America Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 178. Latin America Genetically Modified Drug Sales Market Share by Country (2021-2026) Table 179. Latin America Genetically Modified Drug Sales Forecast by Country (2027-2032) & (k units) Table 180. Latin America Genetically Modified Drug Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Genetically Modified Drug Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Genetically Modified Drug Market Share by Country (2021-2026) Table 184. Latin America Genetically Modified Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Genetically Modified Drug Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 188. Middle East and Africa Genetically Modified Drug Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Genetically Modified Drug Sales Forecast by Country (2027-2032) & (k units) Table 190. Middle East and Africa Genetically Modified Drug Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Genetically Modified Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Genetically Modified Drug Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Genetically Modified Drug Market Share by Country (2021-2026) Table 194. Middle East and Africa Genetically Modified Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Genetically Modified Drug Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Genetically Modified Drug Distributors List Table 199. Genetically Modified Drug Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Genetically Modified Drug Image Figure 2. Global Genetically Modified Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genetically Modified Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Genetically Modified Drug Sales (2021-2032) & (k units) Figure 5. Transgenic Animal Image Figure 6. Global Transgenic Animal Sales YoY Growth (2021-2032) & (k units) Figure 7. Transgenic Plant Image Figure 8. Global Transgenic Plant Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Genetically Modified Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Genetically Modified Drug Market Share by Type 2025 VS 2032 Figure 11. North America Genetically Modified Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Genetically Modified Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Genetically Modified Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Genetically Modified Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Genetically Modified Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Genetically Modified Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Genetically Modified Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Genetically Modified Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Genetically Modified Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Genetically Modified Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Genetically Modified Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Genetically Modified Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Genetically Modified Drug Market Share by Application 2025 VS 2032 Figure 29. North America Genetically Modified Drug Sales Market Share in Volume by Application in 2025 Figure 30. North America Genetically Modified Drug Sales Market Share in Value by Application in 2025 Figure 31. Europe Genetically Modified Drug Sales Market Share in Volume by Application in 2025 Figure 32. Europe Genetically Modified Drug Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Genetically Modified Drug Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Genetically Modified Drug Sales Market Share in Value by Application in 2025 Figure 35. Latin America Genetically Modified Drug Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Genetically Modified Drug Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Genetically Modified Drug Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Genetically Modified Drug Sales Market Share in Value by Application in 2025 Figure 39. North America Genetically Modified Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Genetically Modified Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Genetically Modified Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Genetically Modified Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Genetically Modified Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Genetically Modified Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Genetically Modified Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Genetically Modified Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Genetically Modified Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Genetically Modified Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Genetically Modified Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Genetically Modified Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Genetically Modified Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Genetically Modified Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Genetically Modified Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Genetically Modified Drug Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Genetically Modified Drug Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Transgenic Animal
  • Transgenic Plant
Applications
  • Hospital
  • Clinic
Companies covered
  • Takeda
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Baxter
  • Amgen
  • Pharming Group NV
  • LFB Biotechnologies SA
  • F. Hoffmann-La Roche
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Genetically Modified Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Genetically Modified Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Genetically Modified Drug Market by Type
  6. 1.3.1 Transgenic Animal
  7. 1.3.2 Transgenic Plant
  8. 1.4 Global Genetically Modified Drug Market Size by Type
  9. 1.4.1 Global Genetically Modified Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Genetically Modified Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Genetically Modified Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Genetically Modified Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Genetically Modified Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Genetically Modified Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Genetically Modified Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Genetically Modified Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Genetically Modified Drug Industry Trends
  2. 2.2 Genetically Modified Drug Industry Drivers
  3. 2.3 Genetically Modified Drug Industry Opportunities and Challenges
  4. 2.4 Genetically Modified Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Genetically Modified Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Genetically Modified Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Genetically Modified Drug Price (2021-2026)
  4. 3.4 Global Genetically Modified Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Genetically Modified Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Genetically Modified Drug Company, Product Type & Application
  7. 3.7 Global Genetically Modified Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Genetically Modified Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Genetically Modified Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Genetically Modified Drug Tier 1, Tier 2, and Tier 3
4 Genetically Modified Drug Regional Status and Outlook
  1. 4.1 Global Genetically Modified Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Genetically Modified Drug Historic Market Size by Region
  3. 4.2.1 Global Genetically Modified Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Genetically Modified Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Genetically Modified Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Genetically Modified Drug Forecasted Market Size by Region
  7. 4.3.1 Global Genetically Modified Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Genetically Modified Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Genetically Modified Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Genetically Modified Drug by Application
  1. 5.1 Genetically Modified Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Genetically Modified Drug Market Size by Application
  5. 5.2.1 Global Genetically Modified Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Genetically Modified Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Genetically Modified Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Genetically Modified Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Genetically Modified Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Genetically Modified Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Genetically Modified Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Genetically Modified Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Genetically Modified Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Genetically Modified Drug Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Genetically Modified Drug Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Genetically Modified Drug Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck & Co.
  26. 6.5.1 Merck & Co. Company Information
  27. 6.5.2 Merck & Co. Business Overview
  28. 6.5.3 Merck & Co. Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co. Genetically Modified Drug Product Portfolio
  30. 6.5.5 Merck & Co. Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche Genetically Modified Drug Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Eli Lilly
  38. 6.7.1 Eli Lilly Company Information
  39. 6.7.2 Eli Lilly Business Overview
  40. 6.7.3 Eli Lilly Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly Genetically Modified Drug Product Portfolio
  42. 6.7.5 Eli Lilly Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Genetically Modified Drug Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 GlaxoSmithKline
  50. 6.9.1 GlaxoSmithKline Company Information
  51. 6.9.2 GlaxoSmithKline Business Overview
  52. 6.9.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GlaxoSmithKline Genetically Modified Drug Product Portfolio
  54. 6.9.5 GlaxoSmithKline Recent Developments
  55. 6.10 Baxter
  56. 6.10.1 Baxter Company Information
  57. 6.10.2 Baxter Business Overview
  58. 6.10.3 Baxter Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Baxter Genetically Modified Drug Product Portfolio
  60. 6.10.5 Baxter Recent Developments
  61. 6.11 Amgen
  62. 6.11.1 Amgen Company Information
  63. 6.11.2 Amgen Business Overview
  64. 6.11.3 Amgen Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Amgen Genetically Modified Drug Product Portfolio
  66. 6.11.5 Amgen Recent Developments
  67. 6.12 Pharming Group NV
  68. 6.12.1 Pharming Group NV Company Information
  69. 6.12.2 Pharming Group NV Business Overview
  70. 6.12.3 Pharming Group NV Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Pharming Group NV Genetically Modified Drug Product Portfolio
  72. 6.12.5 Pharming Group NV Recent Developments
  73. 6.13 LFB Biotechnologies SA
  74. 6.13.1 LFB Biotechnologies SA Company Information
  75. 6.13.2 LFB Biotechnologies SA Business Overview
  76. 6.13.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 LFB Biotechnologies SA Genetically Modified Drug Product Portfolio
  78. 6.13.5 LFB Biotechnologies SA Recent Developments
  79. 6.14 F. Hoffmann-La Roche
  80. 6.14.1 F. Hoffmann-La Roche Company Information
  81. 6.14.2 F. Hoffmann-La Roche Business Overview
  82. 6.14.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio
  84. 6.14.5 F. Hoffmann-La Roche Recent Developments
  85. 6.15 Abbott Laboratories
  86. 6.15.1 Abbott Laboratories Company Information
  87. 6.15.2 Abbott Laboratories Business Overview
  88. 6.15.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Abbott Laboratories Genetically Modified Drug Product Portfolio
  90. 6.15.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Genetically Modified Drug Sales by Country
  2. 7.1.1 North America Genetically Modified Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Genetically Modified Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Genetically Modified Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Genetically Modified Drug Market Size by Country
  6. 7.2.1 North America Genetically Modified Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Genetically Modified Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Genetically Modified Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Genetically Modified Drug Sales by Country
  2. 8.1.1 Europe Genetically Modified Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Genetically Modified Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Genetically Modified Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Genetically Modified Drug Market Size by Country
  6. 8.2.1 Europe Genetically Modified Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Genetically Modified Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Genetically Modified Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Genetically Modified Drug Sales by Country
  2. 9.1.1 Asia-Pacific Genetically Modified Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Genetically Modified Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Genetically Modified Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Genetically Modified Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Genetically Modified Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Genetically Modified Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Genetically Modified Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Genetically Modified Drug Sales by Country
  2. 10.1.1 South America Genetically Modified Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Genetically Modified Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Genetically Modified Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Genetically Modified Drug Market Size by Country
  6. 10.2.1 South America Genetically Modified Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Genetically Modified Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Genetically Modified Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Genetically Modified Drug Sales by Country
  2. 11.1.1 Middle East and Africa Genetically Modified Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Genetically Modified Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Genetically Modified Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Genetically Modified Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Genetically Modified Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Genetically Modified Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Genetically Modified Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Genetically Modified Drug Value Chain Analysis
  2. 12.1.1 Genetically Modified Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Genetically Modified Drug Production Mode & Process
  7. 12.2 Genetically Modified Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Genetically Modified Drug Distributors
  10. 12.2.3 Genetically Modified Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst